Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis

Radiation Research

Volumn 152, Issue 3, 1999, Pages 280-292

  Little, M P ^a   Weiss, H A ^b   Boice Jr , J D ^c   Darby, S C ^d   Day, N E ^e   Muirhead, C R ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; ATOMIC BOMB SURVIVOR; CANCER RISK; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; INFANT; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MODEL; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; INFANT; JAPAN; LEUKEMIA; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; SPONDYLITIS, ANKYLOSING; UTERINE CERVICAL NEOPLASMS;

EID: 0032876652     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3580328     Document Type: Article

References (53)

1. J. H. Policy, W. Borges and T. Yamawaki, Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Am. J. Med. 13, 311-321 (1952).
2. K. Mabuchi, M. Soda, E. Ron, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki, D. L. Preston and D. E. Thompson, Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat. Res. 137 (Suppl.), S1-S16 (1994).
3. T. Ishimaru, T. Hoshino, M. Ichimaru, H. Okada, T. Tomiyasu, T. Tsuchimoto and T. Yamamoto, Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 October 1950-30 September 1966. Radiat. Res. 45, 216-233 (1971).
4. D. L. Preston, S. Kusumi, M. Tomonaga, S. Izumi, E. Ron, A. Kuramoto, N. Kamada, H. Dohy, T. Matsuo and K. Mabuchi, Cancer incidence in atomic bomb survivors. Part III: Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat. Res. 137 (Suppl.), S68-S97 (1994).
5. D. A. Pierce, Y. Shimizu, D. L. Preston, M. Vaeth and K. Mabuchi, Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat. Res. 146, 1-27 (1996).
6. United Nations Scientific Committee on the Effects of Atomic Radiation, Sources and Effects of Ionizing Radiation, 1994 Report to the General Assembly, with Scientific Annexes. United Nations, New York, 1994.
7. J. D. Boice, Jr., M. Blettner, R. A. Kleinerman, M. Stovall, W. C. Moloney, G. Engholm, D. F. Austin, A. Bosch, D. L. Cookfair and G. B. Hutchison, Radiation dose and leukemia risk in patients treated for cancer of the cervix. J. Natl Cancer Inst. 79, 1295-1311 (1987).
8. W. M. Court-Brown and R. Doll, Leukaemia and Aplastic Anaemia in Patients Irradiated for Ankylosing Spondylitis. Medical Research Council, London, 1957.
9. H. A. Weiss, S. C. Darby and R. Doll, Cancer mortality following X-ray treatment for ankylosing spondylitis. Int. J. Cancer 59, 327-338 (1994).
10. H. A. Weiss, S. C. Darby, T. Fearn and R. Doll, Leukemia mortality after X-ray treatment for ankylosing spondylitis. Radiat. Res. 142, 1-11 (1995).
11. R. E. Curtis, J. D. Boice, Jr., M. Stovall, L. Bernstein, E. Holowaty, S. Karjalainen, F. Langmark, P. C. Nasca, A. G. Schwartz and W. C. Moloney, Relationship of leukemia risk to radiation dose following cancer of the uterine corpus. J. Natl. Cancer Inst. 86, 1315-1324 (1994).
12. M. P. Little and C. R. Muirhead, Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors. Int. J. Radiat. Biol. 70, 83-94 (1996).
13. D. C. Thomas, M. Blettner and N. E. Day, Use of external rates in nested case-control studies with application to the International Radiation Study of Cervical Cancer patients. Biometrics 48, 781-794 (1992).
14. M. P. Little and C. R. Muirhead, Curvature in the cancer mortality dose response in Japanese atomic bomb survivors: Absence of evidence of threshold. Int. J. Radiat. Biol. 74, 471-480 (1998).
15. National Research Council, Committee on the Biological Effects of Ionizing Radiations, Health Effects of Exposure to Low Levels of Ionizing Radiation (BEIR V). National Academy Press, Washington, DC, 1990.
16. United Nations Scientific Committee on the Effects of Atomic Radiation, Sources and Effects of Ionizing Radiation, 1993 Report to the General Assembly, with Scientific Annexes. United Nations, New York, 1993.
17. ICRP, 1990 Recommendations of the International Commission on Radiological Protection. Publication 60, Annals of the ICRP, Vol. 21, Nos. 1-3. Pergamon Press, Oxford, 1991.
18. M. P. Little, Estimates of neutron relative biological effectiveness derived from the Japanese atomic bomb survivors. Int. J. Radiat. Biol. 72, 715-726 (1997).
19. J. D. Boice, Jr., N. E. Day, A. Andersen, L. A. Brinton, R. Brown, N. W. Choi, E. A. Clarke, M. P. Coleman, R. E. Curtis and C. Wall, Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J. Natl. Cancer Inst. 74, 955-975 (1985).
20. P. McCullagh and J. A. Nelder, Generalized Linear Models, 2nd ed. Chapman and Hall, London, 1989.
21. N. E. Breslow and N. E. Day, Statistical Methods in Cancer Research. Vol. 1 - The Analysis of Case-Control Studies. Scientific Publication No. 32, International Agency for Research on Cancer, Lyon, 1980.
22. D. L. Preston, J. H. Lubin, D. A. Pierce and M. E. McConney, Epicure Release 2.07. HiroSoft International, Seattle, 1997.
23. M. P. Little, F. de Vathaire, M. W. Charles, M. M. Hawkins and C. R. Muirhead, Variations with time and age in the risks of solid cancer incidence after radiation exposure in childhood. Stat. Med. 17, 1341-1355 (1998).
24. W. C. Roesch, Ed., US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki, Vol. 1. Radiation Effects Research Foundation, Hiroshima, 1987.
25. S. C. Darby, G. Reeves, T. Key, R. Doll and M. Stovall, Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica. Int. J. Cancer 56, 793-801 (1994).
26. D. M. Parkin, S. L. Whelan, J. Ferlay, L. Raymond and J. Young, Cancer Incidence in Five Continents. Vol. VI. Scientific Publication No. 143, International Agency for Research on Cancer, Lyon, 1997.
27. D. A. Pierce and M. Vaeth, The shape of the cancer mortality dose-response curve for the A-bomb survivors. Radiat. Res. 126, 36-42 (1991).
28. R. H. Mole, D. G. Papworth and M. J. Corp, The dose-response for X-ray induction of myeloid leukaemia in male CBA/H mice. Br. J. Cancer 47, 285-291 (1983).
29. V. Di Majo, M. Coppola, S. Rebessi, B. Bassani, T. Alati, A. Saran, C. Bangrazi and V. Covelli, Dose-response relationship of radiation-induced harderian gland tumors and myeloid leukemia of the CBA/ Cne mouse. J. Natl. Cancer Inst. 76, 955-966 (1986).
30. E. Cardis, E. S. Gilbert, L. Carpenter, G. Howe, I. Kato, B. K. Armstrong, V. Beral, G. Cowper, A. Douglas and L. D. Wiggs, Effects of low doses and low dose rates of external ionizing radiation: Cancer mortality among nuclear industry workers in three countries. Radiat. Res. 142, 117-132 (1995).
31. G. W. Kneale and A. M. Stewart, Age variation in the cancer risks from foetal irradiation. Br. J. Cancer 35, 501-510 (1977).
32. R. A. Kleinerman, L. G. Littlefield, R. E. Tarone, A. M. Sayer, D. L. Cookfair, J. Wactawski-Wende, P. D. Inskip, A. W. Block, K. H. Ramesh and J. D. Boice, Jr., Chromosome aberrations in lymphocytes from women irradiated for benign and malignant gynecological disease. Radiat. Res. 139, 40-46 (1994).
33. M. C. Baird, J. H. Hendry and N. G. Testa, The radiosensitivity of human haemopoietic progenitor cells. Int. J. Radiat. Biol. 56, 617-621 (1989).
34. D. J. Brenner and E. J. Hall, The inverse dose-rate effect for oncogenic transformation by neutrons and charged particles: A plausible interpretation consistent with published data. Int. J. Radiat. Biol. 58, 745-758 (1990).
35. S. Jablon, Atomic Bomb Radiation Dose Estimation at ABCC. TR 23-71, Atomic Bomb Casualty Commission, Hiroshima, 1971.
36. C. A. Lewis, P. G. Smith, I. M. Stratton, S. C. Darby and R. Doll, Estimated radiation doses to different organs among patients treated for ankylosing spondylitis with a single course of X rays. Br. J. Radiol. 61, 212-220 (1988).
37. M. Stovall, S. A. Smith and M. Rosenstein, Tissue doses from radiotherapy of cancer of the uterine cervix. Med. Phys. 16, 726-733 (1989).
38. R. A. Cartwright, R. J. Q. McNally, D. J. Rowland, J. Thomas, E. Gilman, D. Gorst, G. Morgan, A. Prentice, A. Staines and S. Kuterescz, The Descriptive Epidemiology of Leukaemia and Related Conditions in Parts of the United Kingdom 1984-1993. Leukaemia Research Fund, London, 1997.
39. F. Bessho, Acute non-lymphocytic leukemia is not a major type of childhood leukemia in Japan. Eur. J. Cancer Clin. Oncol. 25, 729-732 (1989).
40. Office of Population Censuses and Surveys, Cancer Statistics Incidence, Survival and Mortality in England and Wales, Studies on Medical and Population Subjects, No. 43. HMSO, London, 1981.
41. M. P. Little, Are two mutations sufficient to cause cancer? Some generalizations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multistage model of Armitage and Doll. Biometrics 51, 1278-1291 (1995).
42. M. P. Little, Generalisations of the two-mutation and classical multi-stage models of carcinogenesis fitted to the Japanese atomic bomb survivor data. J. Radiol. Prot. 16, 7-24 (1996).
43. H. P. Leenhouts and K. H. Chadwick, A two-mutation model of radiation carcinogenesis: Application to lung tumours in rodents and implications for risk evaluation. J. Radiol. Prot. 14, 115-130 (1994).
44. J-F. Boivin, G. B. Hutchison, A. G. Zauber, L. Bernstein, F. G. Davis, R. P. Michel, B. Zanke, C. T. C. Tan, L. M. Fuller and J. E. Ultmann, Incidence of second cancers in patients treated for Hodgkin's disease. J. Natl. Cancer Inst. 87, 732-741 (1995).
45. R. E. Curtis, J. D. Boice, Jr., M. Stovall, L. Bernstein, R. S. Greenberg, J. T. Flannery, A. G. Schwartz, P. Weyer, W. C. Moloney and R. N. Hoover, Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N. Engl. J. Med. 326, 1745-1751 (1992).
46. F. G. Davis, J. D. Boice, Jr., Z. Hrubec and R. R. Monson, Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res. 49, 6130-6136 (1989).
47. M. L. Griem, R. A. Kleinerman, J. D. Boice, Jr., M. Stovall, D. Shefner and J. H. Lubin, Cancer following radiotherapy for peptic ulcer. J. Natl. Cancer Inst. 86, 842-849 (1994).
48. M. M. Hawkins, L. M. Kinnier Wilson, M. A. Stovall, H. B. Marsden, M. H. N. Potok, J. E. Kingston and J. M. Chessells, Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. Br. Med. J. 304, 951-958 (1992).
49. P. D. Inskip, R. A. Kleinerman, M. Stovall, D. L. Cookfair, O. Hadjimichael, W. C. Moloney, R. R. Monson, W. D. Thompson, J. Wactawski-Wende, J. K. Wagoner and J. D. Boice, Jr., Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease. Radiat. Res. 135, 108-124 (1993).
50. J. M. Kaldor, N. E. Day, E. A. Clarke, F. E. van Leeuwen, M. Henry-Amar, M. V. Fiorentino, J. Bell, D. Pedersen and M. Stovall, Leukemia following Hodgkin's disease. N. Engl. J. Med. 322, 7-13 (1990).
51. M. M. Kossenko, M. O. Degteva, O. V. Vyushkova, D. L. Preston, K. Mabuchi and V. P. Kozheurov, Issues in the comparison of risk estimates for the population in the Techa River region and atomic bomb survivors. Radiat. Res. 148, 54-63 (1997).
52. E. Ron, B. Modan and J. D. Boice, Jr., Mortality after radiotherapy for ringworm of the scalp. Am. J. Epidemiol. 127, 713-725 (1988).
53. M. A. Tucker, A. T. Meadows, J. D. Boice, Jr., M. Stovall, O. Oberlin, B. J. Stone, J. Birch, P. A. Voûte, R. N. Hoover and J. F. Fraumeni, Jr., Leukemia after therapy with alkylating agents for childhood cancer. J. Natl. Cancer Inst. 78, 459-464 (1987).